We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Bone Therapeutics

News List

Bone Therapeutics, Rigenerand Ink Cell Therapy Deal contractpharma
January 20, 2021
Bone Therapeutics, a cell therapy company addressing unmet medical needs in orthopedics and other diseases, and Rigenerand SRL, a biotech company that both develops and manufactures medicinal products for cell therapy applications, primarily for ...
Catalent completes acquisition of Bone Therapeutics’ cell therapy manufacturing subsidiary SCTS expresspharma
November 17, 2020
Catalent Pharma Solutions has completed the acquisition of Bone Therapeutics’ manufacturing subsidiary, Skeletal Cell Therapy Support SA (SCTS), announced on 29 October 2020.
Catalent to Acquire Bone Therapeutics’ Cell Therapy Mfg. Facility contractpharma
October 30, 2020
Catalent has signed an agreement with Bone Therapeutics to acquire its cell therapy manufacturing subsidiary, Skeletal Cell Therapy Support SA (SCTS), including all of its assets located in Gosselies, Belgium.
Bone Therapeutics showcases allogeneic cell therapy data pharmatimes
October 16, 2020
Bone Therapeutics has announced positive 24-month follow-up results from its phase IIa study of Allob, its allogeneic cell therapy, in patients undergoing lumbar spinal fusion procedures.